Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Lung Cancer|Non Small Cell Lung Cancer (NSCLC)|Breast Cancer|Estrogen Receptor Breast Cancer
Interventions: DRUG: entinostat|DRUG: entinostat|DRUG: Erlotinib|DRUG: Erlotinib|DRUG: Exemestane|DRUG: Exemestane
Sponsor: Syndax Pharmaceuticals